iDtheinvestordatabase
Home / Directory / Biovance Capital
Active: new deal Sep 2026 Verified 7 Nov 2026

Biovance Capital

Lisbon-based biotech venture capital firm that invests in seed and Series A rounds of early-stage biopharma companies across Europe through a fund backed by the European Investment Fund.

Type
VC firm
Location
Lisbon, Portugal
Stages
Seed, Series A
Sectors
Healthtech and life sciences, Biotech
Fund size / AUM
EUR 60M Fund I (own site)

Contacts on file

For Biovance Capital, the paid file holds: 4 named decision-makers with roles; how to pitch (the route the firm publishes).

Get Europe Complete, $99 Free sample

One-time payment. No subscription. No account.

Notable investments

Mondego BioVaxdyn

Sources

Last checked 7 Nov 2026. Is something wrong? Tell us.

Appears in 15 lists